CL
Not exactly a minty fresh upgrade
Colgate-Palmolive picked up a downgrade from TD Cowen on Tuesday, with analyst Robert Moskow moving the stock from Buy to Hold and cutting his price target to $85 from $96. That’s a pretty clear message: the toothpaste giant may still be a defensive darling, but the easy upside story just got a little less flossy.
Why Wall Street is getting nervous
The catalyst here is ugly in the most boring way possible: higher oil-based input costs. TD Cowen tied the pressure to the Iran war, which can ripple into energy and packaging costs and make life less pleasant for consumer staples companies that rely on steady margins and predictable pricing.
For a company like Colgate, that matters because investors tend to buy it for exactly one thing — stability. If costs start eating into that stability, the stock can lose some of its shelter-from-the-storm appeal. And with earnings expected in about a week, the market is about to find out whether management can pass enough of that pain along without scaring off shoppers.
Big picture
This isn’t a thesis-breaker, but it is a reminder that even the sleepy, dependable names can get whacked by geopolitics and commodities. If you own CL for its defensive vibes, you’ll want to keep an eye on margins, not just toothpaste sales.